Grant C. Sellar

1.4k total citations
21 papers, 1.1k citations indexed

About

Grant C. Sellar is a scholar working on Molecular Biology, Reproductive Medicine and Oncology. According to data from OpenAlex, Grant C. Sellar has authored 21 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 5 papers in Reproductive Medicine and 4 papers in Oncology. Recurrent topics in Grant C. Sellar's work include Ovarian cancer diagnosis and treatment (4 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers) and Alzheimer's disease research and treatments (3 papers). Grant C. Sellar is often cited by papers focused on Ovarian cancer diagnosis and treatment (4 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers) and Alzheimer's disease research and treatments (3 papers). Grant C. Sellar collaborates with scholars based in United Kingdom, United States and Ireland. Grant C. Sellar's co-authors include Hani Gabra, John F. Smyth, Alexander S. Whitehead, Heinz Arnheiter, Minh‐Thanh Nguyen, Roderick R. McInnes, Rashmi Kothary, Genevieve J. Rabiasz, Eric P. Miller and Euan A. Stronach and has published in prestigious journals such as Nature Genetics, PLoS ONE and Development.

In The Last Decade

Grant C. Sellar

20 papers receiving 1.0k citations

Peers

Countries citing papers authored by Grant C. Sellar

Since Specialization

Citations

This map shows the geographic impact of Grant C. Sellar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grant C. Sellar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grant C. Sellar more than expected).

Fields of papers citing papers by Grant C. Sellar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grant C. Sellar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grant C. Sellar. The network helps show where Grant C. Sellar may publish in the future.

Co-authorship network of co-authors of Grant C. Sellar

This figure shows the co-authorship network connecting the top 25 collaborators of Grant C. Sellar. A scholar is included among the top collaborators of Grant C. Sellar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grant C. Sellar. Grant C. Sellar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluation of the dual mTOR/PI3K inhibitors Gedatolisib (PF-05212384) and PF-04691502 against ovarian cancer xenograft models 2019 ·Scientific Reports ·Simon P. Langdon, Charlene Kay, In Hwa Um, Michael Dodds, Morwenna Muir, Grant C. Sellar, Julie L.C. Kan, Charlie Gourley, David J. Harrison	22
2	Comparative Gene Expression Profiling Identifies Common Molecular Signatures of NF-κB Activation in Canine and Human Diffuse Large B Cell Lymphoma (DLBCL) 2013 ·PLoS ONE ·Manikhandan Mudaliar, (unknown), Gino Miele, Grant C. Sellar, Karen A. L. Tan, John R. Goodlad, Elspeth Milne, David M. Vail, Ilene D. Kurzman, Daniel Crowther, David J. Argyle	67
3	Characterisation of tumour-infiltrating macrophages: impact on response and survival in patients receiving primary chemotherapy for breast cancer 2012 ·Breast Cancer Research and Treatment ·Steven D. Heys, Keith N. Stewart, Emma McKenzie, Iain D. Miller, Simon Y. C. Wong, Grant C. Sellar, Andrew J. Rees	26
4	Expression of ovarian tumour suppressor OPCML in the female CD-1 mouse reproductive tract 2009 ·Reproduction ·Jean S. Fleming, H. James McQuillan, (unknown), Grant C. Sellar	1
5	Stoichiometric Quantification of Akt Phosphorylation Using LC-MS/MS 2009 ·Journal of Proteome Research ·Abdelmadjid Atrih, (unknown), Grant C. Sellar, (unknown), Giora Feuerstein, Michael A. J. Ferguson, Jeffrey Huang	21
6	Src pathway activation correlates with treatment resistance in breast cancer and identifies patient subsets predicted to benefit from Src inhibition 2008 ·Clinical Cancer Research ·Christina Coughlin, Marisa Dolled‐Filhart, (unknown), Charles Zacharchuk, Daryl Sonnichsen, (unknown), (unknown), Robert Pinard, Grant C. Sellar, Robin Edwards, Kim Arndt, Frank Boschelli, Michael E. Burczynski	1
7	OPCML Is a Broad Tumor Suppressor for Multiple Carcinomas and Lymphomas with Frequently Epigenetic Inactivation 2008 ·PLoS ONE ·Yan Cui, Ying Ying, Andrew van Hasselt, Ka Man Ng, Jun Yu, Qian Zhang, Jie Jin, Dingxie Liu, Johng S. Rhim, Sun Young Rha, Myriam Loyo, Anthony T.�C. Chan, Gopesh Srivastava, George S.W. Tsao, Grant C. Sellar, Joseph J.�Y. Sung, David Sidransky, Qian Tao	87
8	Correction: OPCML Is a Broad Tumor Suppressor for Multiple Carcinomas and Lymphomas with Frequently Epigenetic Inactivation 2008 ·PLoS ONE ·Yan Cui, Ying Ying, Andrew van Hasselt, Ka Man Ng, Jun Yu, Qian Zhang, Jie Jin, Dingxie Liu, Johng S. Rhim, Sun Young Rha, Myriam Loyo, Anthony T.�C. Chan, Gopesh Srivastava, George Sai‐Wah Tsao, Grant C. Sellar, Joseph J.�Y. Sung, David Sidransky, Qian Tao	11
9	Opportunities Posed by Novel Patient Selection Biomarker Approaches in Oncology Drug Development: Going Beyond the Cytotoxics 2008 ·Biomarkers in Medicine ·Grant C. Sellar, John Alvarez, Frank Loganzo, Richat Abbas, Fred Immermann, Maha Karnoub, Giora Feuerstein, Michael E. Burczynski, Christina Coughlin	0
10	The IgLON Family in Epithelial Ovarian Cancer: Expression Profiles and Clinicopathologic Correlates 2005 ·Clinical Cancer Research ·(unknown), Robert Rush, Derek Anthony Scott, (unknown), Hani Gabra, John F. Smyth, Grant C. Sellar	45
11	OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer 2003 ·Nature Genetics ·Grant C. Sellar, (unknown), Genevieve J. Rabiasz, Euan A. Stronach, Li Li, Eric P. Miller, Charles Massie, (unknown), Bruno Contreras‐Moreira, Derek Anthony Scott, Iain Brown, (unknown), Paul A. Bates, John F. Smyth, Hani Gabra	150
12	Identification of clinically relevant genes on chromosome 11 in a functional model of ovarian cancer tumor suppression. 2003 ·PubMed ·Euan A. Stronach, Grant C. Sellar, Cherie Blenkiron, Genevieve J. Rabiasz, Karen J. Taylor, Eric P. Miller, Charles Massie, Awatif Al‐Nafussi, John F. Smyth, David J. Porteous, Hani Gabra	36
13	Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological parameters. 2002 ·PubMed ·Michael D. Oberst, Michael D. Johnson, Robert B. Dickson, Chen‐Yong Lin, Baljit Singh, Moira Stewart, (unknown), Awatif Al‐Nafussi, John F. Smyth, Hani Gabra, Grant C. Sellar	153
14	The homeobox gene BARX2 can modulate cisplatin sensitivity in human epithelial ovarian cancer 2002 ·International Journal of Oncology ·Grant C. Sellar, (unknown), Li Li, Barry D. Nelkin, Genevieve J. Rabiasz, David J. Porteous, John Smyth, Hani Gabra	13
15	BARX2 induces cadherin 6 expression and is a functional suppressor of ovarian cancer progression. 2001 ·PubMed ·Grant C. Sellar, Li Li, (unknown), Barry D. Nelkin, Genevieve J. Rabiasz, Euan A. Stronach, Eric P. Miller, David J. Porteous, John F. Smyth, Hani Gabra	51
16	High frequency (71%) of cystathionine β-synthase mutation G307S in Irish homocystinuria patients 1995 ·Human Mutation ·Paula Gallagher, (unknown), Soon Guan Tan, E. R. Naughten, Jan P. Kraus, Grant C. Sellar, David J. McConnell, Ian Graham, Alexander S. Whitehead	68
17	The Human Serum Amyloid A Protein (SAA) Superfamily Gene Cluster: Mapping to Chromosome 11p15.1 by Physical and Genetic Linkage Analysis 1994 ·Genomics ·Grant C. Sellar, Siobhán A. Jordan, Wendy A. Bickmore, Judy Fantes, Veronica van Heyningen, Alexander S. Whitehead	43
18	Organization of the Region Encompassing the Human Serum Amyloid A (SAA) Gene Family on Chromosome 11p15.1 1994 ·Genomics ·Grant C. Sellar, (unknown), Shelagh Boyle, Wendy A. Bickmore, Alexander S. Whitehead	25
19	Localization of Four Human Serum Amyloid A (SAA) Protein Superfamily Genes to Chromosome 11p: Characterization of a Fifth SAA-Related Gene Sequence 1993 ·Genomics ·Grant C. Sellar, Alexander S. Whitehead	24
20	A Constitutively Expressed Serum Amyloid A Protein Gene (SAA4) Is Closely Linked to, and Shares Structural Similarities with, an Acute-Phase Serum Amyloid A Protein Gene (SAA2) 1993 ·Genomics ·Diana M. Steel, Grant C. Sellar, Clarissa Uhlar, Susan Simon, (unknown), Alexander S. Whitehead	55

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact